Citadel Advisors’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,000
Closed -$1.98K 13767
2025
Q1
$1.98K Sell
2,000
-2,400
-55% -$3.39K ﹤0.01% 14078
2024
Q4
$7.39K Sell
4,400
-3,400
-44% -$5.61K ﹤0.01% 13741
2024
Q3
$13.7K Sell
7,800
-5,400
-41% -$10.6K ﹤0.01% 13054
2024
Q2
$28.5K Sell
13,200
-13,300
-50% -$35.6K ﹤0.01% 12318
2024
Q1
$79K Sell
26,500
-10,600
-29% -$28.6K ﹤0.01% 11671
2023
Q4
$104K Buy
37,100
+22,300
+151% +$58.5K ﹤0.01% 10881
2023
Q3
$37.6K Buy
+14,800
New +$28.1K ﹤0.01% 12068
2023
Q1
Sell
-500
Closed -$1K 15085
2022
Q4
$1K Buy
+500
New +$1.11K ﹤0.01% 14545

Other funds holding IRIX

Citadel Advisors's IRIX Position: Q1 2026 in Review

Citadel Advisors increased its IRIDEX (IRIX) stake by 77% in Q1 2026, buying an estimated $36.1K and bringing the position to 60,851 shares worth $61.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12320.

Citadel Advisors first reported a position in IRIX in Q2 2021 and has held it in 15 quarters since. The position peaked at $126K in Q3 2025. 25 funds tracked by Wall St. Rank hold IRIX as of Q1 2026.

  • Citadel Advisors held 60,851 shares of IRIDEX worth $61.5K as of Q1 2026.
  • Citadel Advisors bought 26,456 IRIDEX shares in Q1 2026, an estimated $36.1K.
  • IRIDEX made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12320 holding.
  • Citadel Advisors first reported a position in IRIDEX in Q2 2021 and has held it in 15 quarters since.
  • Citadel Advisors's IRIDEX position peaked at $126K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held IRIDEX as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.